VASCULAR GRAFT INFECTIONS — A HISTORICAL REVIEW
Vascular graft infections are still to date a complex medical challenge. The evolution of the hospital flora and development of the vascular surgery field has led to a change in the reality of these infections, making it important to know their current microbiological context in order to provide better care. These infections depend on endogenous and exogenous factors and vary according to the timing of infection, localization and microbiological environment of the patient. There is a high morbidity and mortality associated with these conditions and the treatment must be tailored to patient in question, making it necessary to know the underlying bacteria and the variety of treatment options available. The knowledge of predisposing factors, the high index of suspicion and correct diagnosis and prevention must be performed in all patients and in a multi- disciplinary matter.
2. SiracuseJJ,NandivadaP,GilesKA,etal.Prostheticgraftinfections involving the femoral artery. J Vasc Surg 2013;57:700–5.
3. Batt M, Feugier P, Camou F, et al. A meta-analysis of outcomes after in situ re- constructions for aortic graft infection. Angiology 2018;69(5):370–9.
4. O'Hara PJ, et al. Surgical management of infected abdominal aortic grafts: review of a 25-year experience. J Vasc Surg. 1986;3:725.
5. Gharamti A, Kanafani ZA. Vascular Graft Infections- An update. Infect Dis Clin N Am. 2018 Dec;32(4):789-809
6. Rosenman JE, Pearce WH, Kempczinski RF. Bacterial adherence to vascular grafts after in vitro bacteremia. J Surg Res 1985;38:648–55.
7. Fatima J, Duncan AA, de Grandis E, et al. Treatment strategies and outcomes in patients with infected aortic endografts. J Vasc Surg 2013;58:371–9.
8. Szilagyi DE, Smith RF, Elliott JP, et al. Infection in arterial reconstruction with synthetic grafts. Ann Surg 1972;176:321.
9. Bunt TJ. Synthetic vascular graft infections. I. Graft infections. Surgery 1983; 93(6):733-46.
10. Bunt, T.J., Synthetic vascular graft infections II: graft enteric erosion and graft enteric fistulae. Surgery 1983; 94:1–9.
11. Samson RH, Veith FJ, Janko GS, et al. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J Vasc Surg 1988;8:147–53.
12. Sidawy AN, Perler BA. Rutherford's Vascular Surgery And Endovascular Therapy (9th Edition). Elsevier. 2019: Ch 47: pp 588-682.
13. Hicks RC, Greenhalgh RM. The pathogenesis of vascular graft infection. Eur J Vasc Endovasc Surg 1997;14(Suppl A):5–9.
14. Durham JR, et al. The impact of multiple operations on the importance of arterial wall cultures. J Vasc Surg 1987;5:160.
15. Inui T, Bandyk DF. Vascular surgical site infection: risk factors and preventive measures. Seminars in vascular surgery 2015. 201–7.
16. Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg 2008;47:264–9.
17. Moore WS, Rosson CT, Hall AD, et al. Transient bacteremia: a cause of infection in prosthetic vascular grafts. Am J Surg 1969;117:342–3.
18. Thomas S, Ghosh J, Porter J, et al. Periodontal disease and late- -onset aortic prosthetic vascular graft infection. Case Rep Vasc Med 2015;2015:768935.
19. Vriesendorp T, Morelis Q, Devries J, et al. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endo- vasc Surg 2004;28:520–5.
20. Bowden MG, Chen W, Singvall J, et al. Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis. Microbiology 2005;151:1453–64.
21. Davila VJ, Stone W, Duncan AA, et al. A multicenter experience with the surgical treatment of infected abdominal aortic endografts. J Vasc Surg 2015;62:877–83.
22. Sah BR, Husmann L, Mayer D, et al. Diagnostic performance of 18F-FDG-PET/ CT in vascular graft infections. Eur J Vasc Endovasc Surg 2015;49:455–64.
23. Kilic A, Arnaoutakis DJ, Reifsnyder T, et al. Management of infected vascular grafts. Vasc Med 2016;21:53–60.
24. Calligaro KD, et al. Selective preservation of infected prosthetic grafts: analysis of a 20-year experience with 120 extra-cavitary infected grafts. Ann Surg 1994;220:461.
25. Mayer D, et al. Long-term results of vascular graft and artery preser- ving treatment with negative pressure wound therapy in Szilagyi grade III infections justify a paradigm shift. Ann Surg 2011;254:754.
26. Ricotta JJ, Faggioli GL, Stella A, et al. Total excision and extra-ana- tomic bypass for aortic graft infection. Am J Surg 1991;162:145–9.
27. Seeger JM, et al. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass and aortic graft removal. J Vasc Surg 2000;32:451
28. Clagett GP, et al. Creation of a neo-aortoiliac system from lower extremity deep and superficial veins. Ann Surg 1993;218:239.
29. Beck AW, et al. Aortic reconstruction with femoro-popliteal vein: graft stenosis incidence, risk and reintervention. J Vasc Surg 2008;47:36.
30. Oderich GS, Bower TC, Hofer J, et al. In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula. J Vasc Surg 2011; 53(1):99-106, 107.e1-7.
31. Perler BA, et al. Rotational muscle flaps to treat localized prosthetic graft infection: long-term follow-up. J Vasc Surg 1993;18:358.
32. Silvestre L, Pedro LM, Fernandes RF, Silva E, Fernandes JF. Rectus femoris muscle flap based on proximal insertion mobilization to cover a groin infected vascular graft. J Vasc Surg 2015;62(4):1064-7.
33. Ban K, et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines 2016 update. J Am Coll Surg 2017;224:59.